Filing Details

Accession Number:
0001225208-17-009615
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-05-12 16:58:07
Reporting Period:
2017-05-12
Filing Date:
2017-05-12
Accepted Time:
2017-05-12 16:58:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
310158 Merck & Co. Inc. MRK Pharmaceutical Preparations (2834) 221918501
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1179703 Robert C Kidder
191 W. Nationwide Blvd.
Columbus OH 43215
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-05-12 5,000 $35.19 14,317 No 4 M Direct
Common Stock Disposition 2017-05-12 5,000 $63.54 9,317 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2017-05-12 5,000 $0.00 5,000 $35.19
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2011-08-04 2020-08-03 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,022 Indirect By Trust
Footnotes
  1. The option became exercisable in equal installments on 8/4/2011, 8/4/2012 and 8/4/2013.